<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05078788</url>
  </required_header>
  <id_info>
    <org_study_id>M D 98/ 2020</org_study_id>
    <nct_id>NCT05078788</nct_id>
  </id_info>
  <brief_title>Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture</brief_title>
  <official_title>Efficacy of Holmium Laser Uretherotomy in Combination With Intralesional Steroids in the Treatment of Bulbar Uretheral Stricture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose is to evaluate the outcome of visual internal uretherotomy with Holmium laser&#xD;
      along with intralesional steroid injection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigator evaluates the efficacy of Holmium laser in combination with&#xD;
      intra lesional steroid injection in the treatment of bulbar urethral strictures&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2, 2020</start_date>
  <completion_date type="Actual">September 10, 2021</completion_date>
  <primary_completion_date type="Actual">February 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the maximum flow rate (Qmax) is &gt;15 ml/s at 3 and 6 months after procedure</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>The procedure will be accepted as successful when the maximum flow rate (Qmax) is &gt;15 ml/s.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Urethral Stricture</condition>
  <arm_group>
    <arm_group_label>Laser uretherotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using Holmium laser uretherotomy only in the treatment of bulbar uretheral stricture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laser uretherotomy with intralesional steroids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using holmium laser uretherotomy with injection of 80 mg of triamcinolone (diluted with normal saline to 10 ml) in the treatment of bulbar uretheral stricture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser uretherotomy</intervention_name>
    <description>Holmium YAG Laser with pulse energy from 1-2 Joule, frequency from 10-15 Hertz and total power from 3.0 to 30.0 Watt were set up, respectively, based on the extent of the lesions. Scar tissue was incised at the position of 12-o'clock under the guidance of guidewire or ureteric catheter till fresh mucosa appeared.</description>
    <arm_group_label>Laser uretherotomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser uretherotomy with triamcinolone</intervention_name>
    <description>After laser urethrotomy, 80 mg of triamcinolone (diluted with normal saline to 10 ml) will be injected by using an injection needle (5 F size and 23 G needle size) at 10 sites, 1 ml each, along the site of urethrotomy and circumferentially.</description>
    <arm_group_label>Laser uretherotomy with intralesional steroids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Presence of obstructive symptoms,&#xD;
&#xD;
          2. Short segment strictures (stricture length &lt;2 cm) as evident on radiological studies,&#xD;
             i.e. retrograde urethrography and micturating cystourethrography.&#xD;
&#xD;
          3. Peak flow rate on uroflowmetry less than 15 ml/s&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Complete obliteration of lumen of urethra on urethroscopy,&#xD;
&#xD;
          2. Balanitis Xerotica Obliterans,&#xD;
&#xD;
          3. Age less than 18 years,&#xD;
&#xD;
          4. Multiple strictures,&#xD;
&#xD;
          5. Active urinary tract infection,&#xD;
&#xD;
          6. Recurrent Strictures.&#xD;
&#xD;
          7. Prior internal uretherotomy&#xD;
&#xD;
          8. Prior urethroplasty&#xD;
&#xD;
          9. Pan-anterior urethral strictures&#xD;
&#xD;
         10. Posterior stenosis&#xD;
&#xD;
         11. Those who lost to follow up&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams university</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>October 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urethral Stricture</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

